| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/18/2004 | US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 03/18/2004 | US20040053953 Treatment of chemokine mediated diseases |
| 03/18/2004 | US20040053947 Pyrrolo[2,3-D]pyrimidine compounds |
| 03/18/2004 | US20040053942 Fused pyrazole derivatives bieng protein kinase inhibitors |
| 03/18/2004 | US20040053941 Substituted pyrazine derivatives |
| 03/18/2004 | US20040053937 Pyrimidine compounds |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053931 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 03/18/2004 | US20040053921 Compounds useful as reversible inhibitors of cysteine proteases |
| 03/18/2004 | US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 03/18/2004 | US20040053899 Method of preparing a pharmaceutical composition |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | US20040053867 Nucleotide sequences that code for transport proteins; modulation of excitatory amino acids or signal tranduction; detoxification |
| 03/18/2004 | US20040053860 Flavonoid derivatives for the treatment of eczema |
| 03/18/2004 | US20040053847 Suitable for treatment of cancer and for treatment, particularly topical treatment, of infections caused by pathogenic organisms such as bacteria and fungi |
| 03/18/2004 | US20040053842 Cholesterol ester transfer protein inhibitors for use in treating atherosclerosis optionally in combination with other antihypertensive agents |
| 03/18/2004 | US20040053833 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040052880 Comprises camomile extracts from plants of the genus Matricaria or Anthemis; solvent extraction; treating dermatitis/hay fever |
| 03/18/2004 | US20040052875 Method and perparations having effect against allergic symptoms |
| 03/18/2004 | US20040052870 Cyclooxygenase (COX-2) inhibitors; for treatment/prevention of inflammation; nutraceuticals; for treatment of nervous system disorders |
| 03/18/2004 | US20040052796 Anticancer agents; antitumor agents; controlling gene expression; quantitative analysis |
| 03/18/2004 | US20040052795 Wound healing agents, antiscarring agents |
| 03/18/2004 | US20040052767 Method for cell adhesion and wound healing |
| 03/18/2004 | US20040052759 Lactobacillus fermentated rice; skin brightness, hair texture |
| 03/18/2004 | US20040052754 Complexes of phosphate derivatives |
| 03/18/2004 | US20040052750 Topical applying; adjust collagen biosynthesis; mixture of phenytoin, valproic acid, cyclosporin, nifedipine, diltazem,verapamil hydrochloride and amoldipine |
| 03/18/2004 | US20040052739 Sunscreen agents; radiation resistance |
| 03/18/2004 | CA2498297A1 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | CA2497989A1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2004 | CA2497901A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | CA2497719A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | CA2493974A1 Pharmaceutical dosage form comprising a sulfite compound |
| 03/17/2004 | EP1398326A2 Monoclonal antibodies against recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 03/17/2004 | EP1398036A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/17/2004 | EP1398035A1 Topical cutaneous application of emulsions characterised by their antiprostanoidic properties |
| 03/17/2004 | EP1398034A1 Topical application composition for preventing and treating pediculosis, method of elaboration and uses thereof |
| 03/17/2004 | EP1398033A2 Use of benzodiazepines for treating autoimmune diseases, inflammations, neoplasies, viral infections and atherosclerosis |
| 03/17/2004 | EP1398024A2 Uses for thyroid hormone compounds |
| 03/17/2004 | EP1397507A1 Methods and compositions for treating cardiovascular disease using 10218 |
| 03/17/2004 | EP1397495A2 22437, a human sulfatase and uses therefor |
| 03/17/2004 | EP1397489A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 03/17/2004 | EP1397484A2 Methods and products related to fgf dimerization |
| 03/17/2004 | EP1397382A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 03/17/2004 | EP1397369A1 New use or cyclolignans and new cyclolignans |
| 03/17/2004 | EP1397368A1 New use of specific cyclolignans |
| 03/17/2004 | EP1397365A1 Novel heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 03/17/2004 | EP1397364A1 Novel pyrrole derivatives as pharmaceutical agents |
| 03/17/2004 | EP1397363A1 5-ethyl-imidazotriazinones |
| 03/17/2004 | EP1397360A1 Azaindoles |
| 03/17/2004 | EP1397359A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 03/17/2004 | EP1397356A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 03/17/2004 | EP1397355A1 Pyridyl cyanoguanidine compounds |
| 03/17/2004 | EP1397172A1 Safety shield system for prefilled syringes |
| 03/17/2004 | EP1397170A1 Safety shield system for prefilled syringes |
| 03/17/2004 | EP1397159A2 Stable liquid formulations of antibodies |
| 03/17/2004 | EP1397153A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 03/17/2004 | EP1397150A2 Somatostatin agonists |
| 03/17/2004 | EP1397142A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 03/17/2004 | EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1397124A2 Use of antidiabetics for making a medicine with cicatrizing effect |
| 03/17/2004 | EP1397105A1 Methods for inhibiting angiogenesis |
| 03/17/2004 | EP1292316A4 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use |
| 03/17/2004 | EP1244434B1 Use of chemotherapeutic agents |
| 03/17/2004 | EP1242364B1 Adamantane derivatives |
| 03/17/2004 | EP1147102B1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
| 03/17/2004 | EP1100792B1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP0951471B1 Cycloalkyl inhibitors of protein farnesyltransferase |
| 03/17/2004 | EP0915974B1 Modified tie-2-receptor ligands |
| 03/17/2004 | EP0891362B1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 03/17/2004 | CN1483043A Chitosan-containing multicomponent composition and process for preparing the same |
| 03/17/2004 | CN1483032A Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/17/2004 | CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders |
| 03/17/2004 | CN1483026A Benzoylpyridazine |
| 03/17/2004 | CN1483024A Vla-4 inhibitors |
| 03/17/2004 | CN1483023A 3-arylindole derivatives and their use as cb2 receptor agonists |
| 03/17/2004 | CN1482906A New clinical treatment |
| 03/17/2004 | CN1482897A Use of the association of at least an plant extract of genus rosmarinus and of at least a carotenoid |
| 03/17/2004 | CN1482896A Compositions for prevention and alleviation of skin wrinkles |
| 03/17/2004 | CN1482892A Compositions and methods for treating hyperpigmentation |
| 03/17/2004 | CN1481893A Novel use of boninmycin in curing disease resulted from papillomavirus |
| 03/17/2004 | CN1481890A Ointment for curing scald and its preparation method |
| 03/17/2004 | CN1481880A Ointment for curing tinea on manus and pedes |
| 03/17/2004 | CN1481879A Medication for curing scald or burn |
| 03/17/2004 | CN1481875A Oral liquid for relieving rheumatic pains and stopping itch, and its preparation method |
| 03/17/2004 | CN1481872A Medication for psoriasis and its preparation method |
| 03/17/2004 | CN1481861A Medication of external use for burn and scald |
| 03/17/2004 | CN1481833A Medication of external use for burn or scald |
| 03/17/2004 | CN1481826A Ointment for scald and ulcer and its preparation method |
| 03/17/2004 | CN1481818A A scar-removing acne-controlling formulation and preparation method |
| 03/17/2004 | CN1481817A Powder for trauma |
| 03/17/2004 | CN1142205C Method for producing regular porous cellulose pearls, bead cellulose and use thereof |
| 03/17/2004 | CN1142162C Bicyclic oxazolidinones as antibacterial agents |
| 03/17/2004 | CN1141972C Mongolian-medicinal liniment for disinfecting skin |
| 03/17/2004 | CN1141969C Medicine for treating dermatopathy |
| 03/17/2004 | CN1141967C Externally applied traditional Chinese medicine oil for treating burns and scalds |
| 03/17/2004 | CN1141964C Medicinal pillow for treating freckle |